Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.

Ingold, Caroline; Navarro, Paula Andrea; de Oliveira, Renato; Barbosa, Caio Parente; Bedoschi, Giuliano

Ingold, Caroline; Navarro, Paula Andrea; de Oliveira, Renato; Barbosa, Caio Parente; Bedoschi, Giuliano.

Afiliação

Ingold C; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Navarro PA; Department of Gynecology and Obstetrics, Reproductive Medicine Division, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
de Oliveira R; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Barbosa CP; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Bedoschi G; Department of Gynecology and Obstetrics, Reproductive Medicine Division, Ribeirao Preto Medical School, University of Sao Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto, Sao Paulo 14040-900, Brazil.

Ther Adv Reprod Health ; 17: 26334941231196545, 2023.

Article em En | MEDLINE | ID: mdl-37674690

Palavras-chave

fertility preservation; gonadotropin-releasing hormone; neoplasms; ovarian hyperstimulation syndrome; ovulation induction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Ther Adv Reprod Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google